60 Degrees Pharmaceuticals Implements 1-for-4 Reverse Stock Split to Maintain Nasdaq Listing

summarizeSummary

60 Degrees Pharmaceuticals, Inc. has implemented a 1-for-4 reverse stock split, effective January 20, 2026, primarily to regain compliance with Nasdaq's minimum bid price requirement.

check_boxKey Events

• Reverse Stock Split Effective

  A 1-for-4 reverse stock split became effective on January 20, 2026, at 12:01 a.m. Eastern Time.

• Nasdaq Compliance Driver

  The primary purpose of the reverse stock split is to bring the company into compliance with Nasdaq's minimum bid price requirement for continued listing.

• Share Count Reduction

  The split will reduce the number of issued and outstanding common shares from approximately 5.15 million to 1.29 million.

• Fractional Share Treatment

  No fractional shares will be issued; any fractional amounts will be rounded up to one whole share.

auto_awesomeAnalysis

60 Degrees Pharmaceuticals, Inc. has executed a 1-for-4 reverse stock split, a critical move primarily aimed at regaining compliance with Nasdaq's minimum bid price requirement. While this action addresses an immediate delisting threat, reverse stock splits are generally viewed negatively by the market as they often signal a company's struggle with sustained low stock prices. Investors should monitor whether the company can maintain its listing and demonstrate fundamental business improvements to support the higher per-share price, as the split itself does not alter the company's underlying valuation or operational challenges.